A study has been conducted to investigate the relationships between the risk of developing various pathogenetic subtypes of ischemic stroke (IS) and its outcomes with chronic kidney disease (CKD). A retrospective study was conducted in the group of IS patients (n=1070): with CKD (n=343) and without CKD (n=727). TOAST classification was used to determine IS subtypes. The study data showed that in patients with CKD compared to patients without CKD, TOAST2 frequency was more common in total group (p<0.0001; OR=1.878 (1.423-2.478)), among men (p<0.001; OR=2.008 (1.370-2.943)) and among women (p=0.009; OR=1.720 (1.145-2.584)); TOAST1 frequency was rare in total group (p<0.0001; OR=0.565 (0.435-0.734)), among men (p<0.0001; OR=0.502 (0.353-0.713)) and among women (p=0.042; OR=0.665 (0.448-0.487)); stroke manifestations were more severe an NIHSS scale (p=0.0001), Glasgow coma scale (p=0.002); IS mortality was higher (13.7 % versus 7.4 %; p=0.001;) in total group and TOAST2 mortality was higher (25.0 % vs.14.9 %; p=0.027; OR=1.910 (1.072-3.404) in total group and among women (29.7 % versus 11.1 %; p=0.004; )). Conclusions. IS patients with CKD are more likely to develop cardioembolic stroke (p<0.0001; OR=1.878 (1.423-2.478)), have more severe stroke manifestations (NIHSS score, p=0.0001; Glasgow score, p=0.002), have higher cardioembolic stroke mortality among women (29.7 % versus 11.1 %; p=0.004;) compared to IS patients without CKD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.